A Study of Isoquercetin in People With Ovarian Cancer
Status:
NOT_YET_RECRUITING
Trial end date:
2032-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether isoquercetin can reduce markers in the blood that may indicate the risk of blood clots in people with ovarian cancer. The effects of isoquercetin will be compared with those of a placebo.